2-deoxy-D-glucose(2-DG), a medicine developed by the Defence Research and Development Organisation(DRDO) for the treatment of Covid-19 patients.
Dr. Reddy’s will supply to major Government as well as private hospitals across India. In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India.
2-DG manufactured by Dr. Reddy’s has a purity of 99.5% and is being sold commercially under the brand name 2DGTM. The maximum retail price (MRP) of each sachet has been fixed at Rs.
990, with a subsidized rate offered to Government institutions. 2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the